Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation for the Efficacy,Tolerability,and Safety of Rasagiline in Levodopa-treated PD Patients With Motor Fluctuations: A Multicenter, Double Blind, Randomized, Placebo-Controlled Group Study (China)

NCT01736891 is registered in ClinicalTrials.gov with Chongqing Fortune Pharmaceutical Co., Ltd. as lead sponsor.

NCT NCT01736891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01736891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation for the Efficacy,Tolerability,and Safety of Rasagiline in Levodopa-treated PD Patients With Motor Fluctuations: A Multicenter, Double Blind, Randomized, Placebo-Controlled Group Study (China)
Lead sponsor
Chongqing Fortune Pharmaceutical Co., Ltd.
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2011
Completion date
June 30, 2013
Enrollment
268 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson´s disease